Vimarsana
Biggest News Aggregation in the World

Page 14 - Mployee Wellness Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mployee Wellness Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mployee Wellness Programs Today - Breaking & Trending Today

HealthSnap Snags $25M to Help Providers Launch & Scale RPM Programs - Vimarsana News

HealthSnap Snags $25M to Help Providers Launch & Scale RPM Programs

HealthSnap closed a $25 million Series B funding round led by Sands Capital. The Miami-based company seeks to help providers better care for a rapidly aging and chronically ill population through its remote patient monitoring platform.

At ViVE 2024, Get a Glimpse of the State of Cybersecurity in Healthcare - Vimarsana News

At ViVE 2024, Get a Glimpse of the State of Cybersecurity in Healthcare

Mari Savickis, Vice President of Public Policy with CHIME, will be moderating a panel discussion as part of the Cybersecurity Pavilion at the ViVE 2024  event in Los Angeles, scheduled for February 25-28. She said her organization anticipates several developments addressing cybersecurity this year.

Menopause Startup Raises $3.3M in Funding Led By UPMC - Vimarsana News

Menopause Startup Raises $3.3M in Funding Led By UPMC

Elektra Health, a virtual provider for menopause care, has secured $3.3 million in financing. With the funding, the company is focused on two areas: partnering with more payers and expanding its footprint to provide clinical care to more patients.

Medication Management Technology Puts Patient Safety at the Center of Care - Vimarsana News

Medication Management Technology Puts Patient Safety at the Center of Care

In the same way that airbags were a natural evolution of vehicle safety technology, seamless, RFID-based systems are the next evolution of medication management technology.

FDA Approves Iovance Cancer Treatment, the First Cell Therapy for a Solid Tumor - Vimarsana News

FDA Approves Iovance Cancer Treatment, the First Cell Therapy for a Solid Tumor

Iovance Biotherapeutics’s Amtagvi is now the first FDA-approved treatment based on type of cell called a tumor-infiltrating lymphocyte. The regulatory nod in advanced melanoma also makes Amtagvi the first cell therapy approved for treating a solid tumor.